Stifel Nicolaus analyst Stephen Gengaro maintained a Buy rating on Caliber Imaging & Diagnostic (LCDX – Research Report) yesterday and set ...

In a report released yesterday, Mathew Blackman from Stifel Nicolaus maintained a Hold rating on AdaptHealth (AHCO – Research Report), with a ...

US Stocks Likely To Open Higher After Nvidia's Blowout Earnings: 'This Is Still A Bull Market,' Says Expert Michigan ...

Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is ...

Stifel analyst Mark Astrachan downgraded ARKO Corp (NASDAQ: ARKO) from Buy to Hold, reducing the price target to $7.5. ARKO's fourth-quarter results showed weaker-than-expected adjusted EBITDA and ...

Artivion (NYSE:AORT – Get Free Report) had its target price reduced by equities research analysts at Stifel Nicolaus from $33 ...

PRIEST RIVER — It was a back-and-forth game until the very end, but the No. 2 Lumberjacks bested the No. 1 Spartans in a 3A ...

Illuma is continuing to expand the market reach of its voice biometrics for financial institutions with strategic financing ...

Inflation probably isn't going back to 2% without a recession, according to Barry Bannister, Stifel's top stock strategist.

We recently compiled a list of the Top 10 AI Stocks on Wall Street’s Radar Right Now. In this article, we are going to take a ...

A paper published in The Lancet showed that four out of four young children with Leber congenital amaurosis 4 retinal dystrophy due to a genetic deficiency of Aryl-hydrocarbon-interacting protein-like ...

With Trevi poised to soon announce data from a trial of its Haduvio drug as a treatment for refractory chronic cough (RCC), ...